Cabot (CBT) YoY EBITDA Growth: -38.61% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CBT Cabot Corp CBT
82 GF Score
Price $79.20
GF Value $81.18
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cabot YoY EBITDA Growth?

Cabot CBT -1.93% 82 YoY EBITDA Growth is -38.61% as of Jun. 2026. GuruFocus rates CBT with a GF Score™ of 82/100 and a GF Value™ of $81.18 (Fairly Valued). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cabot's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -38.61%.

Cabot's EBITDA per Share for the three months ended in Jun. 2026 was $2.44.

Cabot YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Cabot's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabot YoY EBITDA Growth Chart

Cabot Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 240.21 -12.61 28.26 12.47 7.34

Cabot Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 -5.72 -7.45 -6.25 -38.61
CBT
82GF Score
Cabot Corp CBT
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabot YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cabot's YoY EBITDA Growth for the fiscal year that ended in Sep. 2025 is calculated as:

YoY EBITDA Growth (A: Sep. 2025 )
=(EBITDA per Share (A: Sep. 2025 )-EBITDA per Share (A: Sep. 2024 ))/ | EBITDA per Share (A: Sep. 2024 ) |
=(14.723-13.716)/ | 13.716 |
=7.34 %

Cabot's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(2.442-3.978)/ | 3.978 |
=-38.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -38.61% mean?
Cabot (CBT) has a YoY EBITDA Growth of -38.61% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cabot and its competitors.
Is Cabot's YoY EBITDA Growth too high?
Cabot's current YoY EBITDA Growth is -38.61%. Overall, Cabot has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cabot's YoY EBITDA Growth compare to CLMT and AVNT?
Cabot's YoY EBITDA Growth of -38.61% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cabot and its competitors. Cabot's current YoY EBITDA Growth is -38.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabot stock overvalued right now?
Based on GuruFocus' analysis, Cabot (CBT) is currently considered Fairly Valued. The stock's GF Value™ is $81.18, compared to a current price of $79.20 — trading 2.4% below its estimated fair value. The current YoY EBITDA Growth is -38.61%. Cabot's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Cabot (CBT), the current YoY EBITDA Growth is -38.61% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cabot (CBT) Overvalued in 2026?

Based on GuruFocus' analysis, Cabot stock appears to be undervalued. The current stock price of $79.20 is trading 2.4% below its estimated GF Value™ of $81.18. GuruFocus considers Cabot to be Fairly Valued.

Key valuation signals for CBT:

  • YoY EBITDA Growth: -38.61%
  • GF Value™: $81.18 vs. price of $79.20 (2.4% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cabot Business Description

Other Exchanges CBT:Germany
Address Two Seaport Lane, Suite 1400, Boston, MA, USA, 02210
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
82GF Score

Get the complete analysis for CBT

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.20
Price
$81.18
GF Value